ArticleInternal medicine (Tokyo, Japan)2026
The Assessment of Interatrial Septum Thickness by Echocardiography in Wild-type Transthyretin Amyloidosis.
Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective Thickening of the interatrial septum (IAS) is one of red flags for cardiac amyloidosis (CA), but the available evidence concerning it is poor. We evaluated the IAS thickness (IAST) using transthoracic echocardiography to determine the criteria for thickening of the IAS for diagnosing wild-type transthyretin cardiac amyloidosis (ATTRwt-CA). Methods We reviewed 60 patients with ATTRwt-CA (mean age: 78.7±5.6 years old, 50 men) and 56 control individuals (mean age: 74.3±6.1 years old, 29 men) with normal echocardiographic findings. We measured the end-diastolic and end-systolic (ES) IAST in the middle region of the anterior atrial septum in an apical four-chamber view and a subcostal four-chamber view. Results The IAST was significantly greater in patients in the ATTRwt-CA group than in the control group at both sites and phases. In a receiver operating characteristic analysis to discriminate ATTRwt-CA patients from control subjects, the best cutoff value of IAST was 5.2 mm, which was measured at ES in a subcostal four-chamber view, with a sensitivity of 80.0% and specificity of 78.6%. There was no significant correlation between the IAST and disease stage of ATTRwt-CA. Conclusion An IAST ≥5.2 mm measured in a zoomed subcostal four-chamber view at ES might be useful for detecting ATTRwt-CA, regardless of the disease stage of CA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.